UniProt ID | QRIC1_HUMAN | |
---|---|---|
UniProt AC | Q2TAL8 | |
Protein Name | Glutamine-rich protein 1 | |
Gene Name | QRICH1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 776 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MNNSLENTISFEEYIRVKARSVPQHRMKEFLDSLASKGPEALQEFQQTATTTMVYQQGGNCIYTDSTEVAGSLLELACPVTTSVQPQTQQEQQIQVQQPQQVQVQVQVQQSPQQVSAQLSPQLTVHQPTEQPIQVQVQIQGQAPQSAAPSIQTPSLQSPSPSQLQAAQIQVQHVQAAQQIQAAEIPEEHIPHQQIQAQLVAGQSLAGGQQIQIQTVGALSPPPSQQGSPREGERRVGTASVLQPVKKRKVDMPITVSYAISGQPVATVLAIPQGQQQSYVSLRPDLLTVDSAHLYSATGTITSPTGETWTIPVYSAQPRGDPQQQSITHIAIPQEAYNAVHVSGSPTALAAVKLEDDKEKMVGTTSVVKNSHEEVVQTLANSLFPAQFMNGNIHIPVAVQAVAGTYQNTAQTVHIWDPQQQPQQQTPQEQTPPPQQQQQQLQVTCSAQTVQVAEVEPQSQPQPSPELLLPNSLKPEEGLEVWKNWAQTKNAELEKDAQNRLAPIGRRQLLRFQEDLISSAVAELNYGLCLMTREARNGEGEPYDPDVLYYIFLCIQKYLFENGRVDDIFSDLYYVRFTEWLHEVLKDVQPRVTPLGYVLPSHVTEEMLWECKQLGAHSPSTLLTTLMFFNTKYFLLKTVDQHMKLAFSKVLRQTKKNPSNPKDKSTSIRYLKALGIHQTGQKVTDDMYAEQTENPENPLRCPIKLYDFYLFKCPQSVKGRNDTFYLTPEPVVAPNSPIWYSVQPISREQMGQMLTRILVIREIQEAIAVANASTMH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNNSLENT -------CCCCCCCC | 10.92 | 22814378 | |
14 | Phosphorylation | NTISFEEYIRVKARS CCCCHHHHHHHHHCC | 6.19 | - | |
28 | Sumoylation | SVPQHRMKEFLDSLA CCCHHHHHHHHHHHH | 45.32 | - | |
28 | Ubiquitination | SVPQHRMKEFLDSLA CCCHHHHHHHHHHHH | 45.32 | 21890473 | |
28 | Sumoylation | SVPQHRMKEFLDSLA CCCHHHHHHHHHHHH | 45.32 | - | |
215 | Phosphorylation | GQQIQIQTVGALSPP CCEEEEEEEEECCCC | 23.65 | 26074081 | |
220 | Phosphorylation | IQTVGALSPPPSQQG EEEEEECCCCHHHCC | 34.52 | 26074081 | |
224 | Phosphorylation | GALSPPPSQQGSPRE EECCCCHHHCCCCCC | 40.69 | 26074081 | |
228 | Phosphorylation | PPPSQQGSPREGERR CCHHHCCCCCCCCCC | 19.22 | 26074081 | |
238 | Phosphorylation | EGERRVGTASVLQPV CCCCCCCCHHHCCCC | 16.95 | 26074081 | |
240 | Phosphorylation | ERRVGTASVLQPVKK CCCCCCHHHCCCCCC | 24.17 | 25159151 | |
246 | Sumoylation | ASVLQPVKKRKVDMP HHHCCCCCCCCCCCC | 54.25 | - | |
246 | Ubiquitination | ASVLQPVKKRKVDMP HHHCCCCCCCCCCCC | 54.25 | - | |
246 | Sumoylation | ASVLQPVKKRKVDMP HHHCCCCCCCCCCCC | 54.25 | - | |
246 | Acetylation | ASVLQPVKKRKVDMP HHHCCCCCCCCCCCC | 54.25 | 25953088 | |
247 | Methylation | SVLQPVKKRKVDMPI HHCCCCCCCCCCCCE | 58.65 | 116252817 | |
247 | Ubiquitination | SVLQPVKKRKVDMPI HHCCCCCCCCCCCCE | 58.65 | - | |
255 | O-linked_Glycosylation | RKVDMPITVSYAISG CCCCCCEEEEEEECC | 9.49 | 30059200 | |
257 | O-linked_Glycosylation | VDMPITVSYAISGQP CCCCEEEEEEECCCE | 10.53 | 30059200 | |
302 | Phosphorylation | YSATGTITSPTGETW EEEECEEECCCCCCE | 28.61 | 26074081 | |
303 | Phosphorylation | SATGTITSPTGETWT EEECEEECCCCCCEE | 19.33 | 26074081 | |
305 | Phosphorylation | TGTITSPTGETWTIP ECEEECCCCCCEEEE | 47.63 | 26074081 | |
308 | Phosphorylation | ITSPTGETWTIPVYS EECCCCCCEEEEEEE | 29.29 | 26074081 | |
326 | Phosphorylation | RGDPQQQSITHIAIP CCCCCCCCEEEEECC | 25.72 | 29978859 | |
328 | Phosphorylation | DPQQQSITHIAIPQE CCCCCCEEEEECCHH | 16.69 | 29978859 | |
337 | Phosphorylation | IAIPQEAYNAVHVSG EECCHHHHHCEEECC | 11.69 | 27794612 | |
343 | Phosphorylation | AYNAVHVSGSPTALA HHHCEEECCCCCEEE | 20.76 | 25159151 | |
345 | Phosphorylation | NAVHVSGSPTALAAV HCEEECCCCCEEEEE | 16.15 | 23401153 | |
347 | Phosphorylation | VHVSGSPTALAAVKL EEECCCCCEEEEEEC | 35.68 | 25159151 | |
353 | Ubiquitination | PTALAAVKLEDDKEK CCEEEEEECCCCCHH | 41.24 | - | |
353 | Sumoylation | PTALAAVKLEDDKEK CCEEEEEECCCCCHH | 41.24 | 28112733 | |
358 | Sumoylation | AVKLEDDKEKMVGTT EEECCCCCHHEECCE | 72.12 | 28112733 | |
360 | Sumoylation | KLEDDKEKMVGTTSV ECCCCCHHEECCEEH | 44.63 | - | |
360 | Sumoylation | KLEDDKEKMVGTTSV ECCCCCHHEECCEEH | 44.63 | - | |
360 | Ubiquitination | KLEDDKEKMVGTTSV ECCCCCHHEECCEEH | 44.63 | - | |
361 | Sulfoxidation | LEDDKEKMVGTTSVV CCCCCHHEECCEEHH | 3.35 | 21406390 | |
364 | Phosphorylation | DKEKMVGTTSVVKNS CCHHEECCEEHHCCC | 12.42 | - | |
364 | O-linked_Glycosylation | DKEKMVGTTSVVKNS CCHHEECCEEHHCCC | 12.42 | 30059200 | |
365 | O-linked_Glycosylation | KEKMVGTTSVVKNSH CHHEECCEEHHCCCH | 17.37 | 30059200 | |
371 | Phosphorylation | TTSVVKNSHEEVVQT CEEHHCCCHHHHHHH | 26.93 | - | |
459 | Phosphorylation | VAEVEPQSQPQPSPE EEEECCCCCCCCCCC | 55.32 | 26074081 | |
464 | Phosphorylation | PQSQPQPSPELLLPN CCCCCCCCCCCCCCC | 26.26 | 26657352 | |
472 | Phosphorylation | PELLLPNSLKPEEGL CCCCCCCCCCHHHHH | 35.51 | 26074081 | |
474 | Sumoylation | LLLPNSLKPEEGLEV CCCCCCCCHHHHHHH | 50.64 | - | |
489 | Sumoylation | WKNWAQTKNAELEKD HHHHHHHCCHHHHHH | 41.92 | - | |
489 | Sumoylation | WKNWAQTKNAELEKD HHHHHHHCCHHHHHH | 41.92 | - | |
489 | Ubiquitination | WKNWAQTKNAELEKD HHHHHHHCCHHHHHH | 41.92 | 21890473 | |
495 | Ubiquitination | TKNAELEKDAQNRLA HCCHHHHHHHHHCCC | 71.62 | 21890473 | |
500 | Methylation | LEKDAQNRLAPIGRR HHHHHHHCCCCCCHH | 21.83 | 115489779 | |
586 | Ubiquitination | EWLHEVLKDVQPRVT HHHHHHHHHCCCCCC | 62.11 | - | |
618 | Phosphorylation | CKQLGAHSPSTLLTT HHHCCCCCHHHHHHH | 21.73 | 20068231 | |
620 | Phosphorylation | QLGAHSPSTLLTTLM HCCCCCHHHHHHHHH | 34.40 | 28270605 | |
621 | Phosphorylation | LGAHSPSTLLTTLMF CCCCCHHHHHHHHHH | 29.22 | 28270605 | |
624 | Phosphorylation | HSPSTLLTTLMFFNT CCHHHHHHHHHHHCH | 22.46 | 28270605 | |
625 | Phosphorylation | SPSTLLTTLMFFNTK CHHHHHHHHHHHCHH | 19.05 | 28270605 | |
631 | Phosphorylation | TTLMFFNTKYFLLKT HHHHHHCHHCHHHHH | 23.20 | 28270605 | |
637 | Ubiquitination | NTKYFLLKTVDQHMK CHHCHHHHHHHHHHH | 48.96 | - | |
644 | Ubiquitination | KTVDQHMKLAFSKVL HHHHHHHHHHHHHHH | 34.24 | - | |
649 | Ubiquitination | HMKLAFSKVLRQTKK HHHHHHHHHHHHHCC | 38.54 | - | |
649 | Acetylation | HMKLAFSKVLRQTKK HHHHHHHHHHHHHCC | 38.54 | 25953088 | |
655 | Malonylation | SKVLRQTKKNPSNPK HHHHHHHCCCCCCCC | 42.06 | 26320211 | |
659 | Phosphorylation | RQTKKNPSNPKDKST HHHCCCCCCCCCHHH | 75.14 | 23403867 | |
662 | Ubiquitination | KKNPSNPKDKSTSIR CCCCCCCCCHHHHHH | 80.28 | - | |
664 | Ubiquitination | NPSNPKDKSTSIRYL CCCCCCCHHHHHHHH | 62.86 | - | |
672 | Sumoylation | STSIRYLKALGIHQT HHHHHHHHHCCCCCC | 32.41 | - | |
672 | Ubiquitination | STSIRYLKALGIHQT HHHHHHHHHCCCCCC | 32.41 | - | |
672 | Sumoylation | STSIRYLKALGIHQT HHHHHHHHHCCCCCC | 32.41 | - | |
679 | Phosphorylation | KALGIHQTGQKVTDD HHCCCCCCCCCCCCC | 27.67 | 28555341 | |
682 | Ubiquitination | GIHQTGQKVTDDMYA CCCCCCCCCCCCCHH | 48.74 | 21890473 | |
682 | Acetylation | GIHQTGQKVTDDMYA CCCCCCCCCCCCCHH | 48.74 | 26051181 | |
684 | Phosphorylation | HQTGQKVTDDMYAEQ CCCCCCCCCCCHHHC | 33.06 | 20860994 | |
704 | Ubiquitination | NPLRCPIKLYDFYLF CCCCCCEEEEEEEEE | 26.57 | - | |
712 | Ubiquitination | LYDFYLFKCPQSVKG EEEEEEEECCCCCCC | 42.27 | 21890473 | |
775 | Sulfoxidation | AVANASTMH------ HHHCHHCCC------ | 3.06 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of QRIC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of QRIC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of QRIC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NUDC3_HUMAN | NUDCD3 | physical | 22863883 | |
GLU2B_HUMAN | PRKCSH | physical | 22863883 | |
RL11_HUMAN | RPL11 | physical | 22863883 | |
SP16H_HUMAN | SUPT16H | physical | 22863883 | |
QRIC1_HUMAN | QRICH1 | physical | 25416956 | |
GMCL1_HUMAN | GMCL1 | physical | 25416956 | |
SPF45_HUMAN | RBM17 | physical | 25416956 | |
HSFY1_HUMAN | HSFY1 | physical | 25416956 | |
A4_HUMAN | APP | physical | 15923395 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND MASSSPECTROMETRY. |